Black Enterprise Women In U.S. Have Limited Access To Less Expensive, Invasive Breast Cancer Treatment
The Food and Drug Administration (FDA) approved IORT in 1999. It’s a treatment that involves just a single dose of radiation to a patient’s breast tissue after surgery, compared to whole or partial breast radiation treatments.